1yon der MH, Hansen SW , Roberts , et al . Gemcitabine and cisplatin versus methotrexate , vinblastine , doxorubcin , and cisplatin in advanced or matastatic bladder cancer : results of a large , randomized , multinational , muhicenter , phase Ⅲ study[ J ]. J Clin Oncol , 2000 , 18(17) : 3068-3077. 被引量：1
2Culine S, Rebillard X, Iborra F, et al. Gemcitabine and oxaliplatin in advanced transitional carcinoma of the urothelium: a pilot study[J]. Anticancer Res,2003 , 23(2C) : 1903-1906. 被引量：1
3Caries J, Esteban E, Climent M, et al . Gemcitabine and oxaliplatin combination: a muhicenter phase Ⅱ trial in unfit patients with locally advanced or matastatic urothelial cancer [ J ]. Ann Oncol , 2007 , 18(8) : 1359-1362. 被引量：1
4Theodore C , Bidauh F , Bouvet-Forteau N, et al . Phase Ⅱ monocentric study of oxaliplatin in combination with gemcitabine ( GEMOX ) in patients with locally advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract [ J ]. Ann Oncol , 2006 , 17(6) : 990-994. 被引量：1
5Mir O , Alexandre J , Ropert S , et al . Combination of gemcitabine and oxaliplatin in urothelial cancer patients with severe renal or cardiac comorbidities [ J ]. Anti-Cancer Drugs , 2005 , 16 (9) : 1017-1021. 被引量：1
9Sternberg CN,Pansadoro V,Calabro F,et al.Can patient selection for bladder preservation be based on response to chemotherapy[J] ?Cancer,2003,97(7):1644-1652. 被引量：1
10Von der Maase H,Hansen SW,Roberts JT,et al.Gemcitabine and cisplatin versus methotrexate,viblastine,doxorubcin,and cisplatin in advanced or metastatic bladder cancer:results of a large,randomized,multinational,multicenter,phase III study[J].J Clin Onco1,2000,18(17):3068-3077. 被引量：1
